Skip to main content
SpringerLink
Log in

Speicherkrankheit, die zu Fibrose, Zirrhose und hepatozellulärem Karzinom führen kann

Alpha-1-Antitrypsin-Defizienz (AATD): Auch an die Leber denken!

Liver disease associated with alpha1 antitrypsin deficiency

  • FB_Übersicht
  • Published:
MMW - Fortschritte der Medizin Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1

Author information

Authors and Affiliations

  1. Katholische Kliniken Oberhausen, c/o Postfach 10 12 03, 46012, Oberhausen, Deutschland

    Claus Niederau (em. Chefarzt)

Authors
  1. Claus Niederau
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Claus Niederau.

Ethics declarations

Prof. Dr. Claus Niederau hat in den vergangenen drei Jahren Honorare für Studien, Beratung und Vorträge von den Firmen Abbvie, Falk, Gilead, MSD, Sanofi und Takeda erhalten.

Supplementary Information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Niederau, C. Alpha-1-Antitrypsin-Defizienz (AATD): Auch an die Leber denken!. MMW Fortschr Med 166 (Suppl 1), 23–25 (2024). https://doi.org/10.1007/s15006-023-3519-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15006-023-3519-2

Keywords:

Search

Navigation